APOBEC3G versus reverse transcriptase in the generation of HIV-1 drug-resistance mutations
- 1 September 2004
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 18 (13) , 1861-1863
- https://doi.org/10.1097/00002030-200409030-00022
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Unselected Mutations in the Human Immunodeficiency Virus Type 1 Genome Are Mostly Nonsynonymous and Often DeleteriousJournal of Virology, 2004
- DNA Deamination Mediates Innate Immunity to Retroviral InfectionCell, 2003
- The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNANature, 2003
- Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcriptsNature, 2003
- Hypermutation of HIV-1 DNA in the Absence of the Vif ProteinScience, 2003
- Exploitation of the Low Fidelity of Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase and the Nucleotide Composition Bias in the HIV-1 Genome To Alter the Drug Resistance Development of HIVJournal of Virology, 2001
- HIV-1 RNA Editing, Hypermutation, and Error-Prone Reverse TranscriptionScience, 2001
- Enhanced Fidelity of 3TC-Selected Mutant HIV-1 Reverse TranscriptaseScience, 1996
- The tendency of lentiviral open reading frames to become A-rich: constraints imposed by viral genome organization and cellular tRNA availabilityJournal of Molecular Evolution, 1995
- The unusual nucleotide content of the HIV RNA genome results in a biased amino acid composition of HIV proteinsNucleic Acids Research, 1994